Digging Deeper Into the TP53 Mutation in AML with Rory Shallis, MD, Yale New Haven Hospital
Digging Deeper Into the TP53 Mutation in AML with Rory Shallis, MD, Yale New Haven Hospital image
Jul 14, 2022 / 11:00AM - 12:00PM EDT
HealthTree Podcast for AML

Event Description

IF YOU WOULD PREFER TO JOIN THE SHOW BY PHONE, PLEASE CALL (515) 602-9728

*You need to join by phone if you want to ask Dr. Shallis your questions.*

The TP53 mutation in AML is considered to be a high risk mutation and occurs in approximately 5-10% of patients. This genetic mutation has been difficult to treat, often being chemoresistant with a poor prognosis, however, the research indicates progress is being made in this area. 

Join us live on Thursday, July 14th at 11 am EST to hear from Dr. Rory Shallis with Yale New Haven Hospital who will be discussing the TP53 mutation in AML, current treatment options available, and the latest research and clinical trials using novel investigational agents to target this mutation. There will be time at the end of the show to ask Dr. Shallis your questions directly!

Thank you to our episode sponsor, Bristol Myers Squibb.

Schedule & Agenda

person
Welcome
11:00AM
Kerith Amen
Welcome, Announcements & Introduction
person
Interview
11:05AM
Dr. Rory Shallis
Dr. Shallis will discuss the TP53 mutation in AML and the current treatment options available, as well as clinical trials exploring the latest research and novel drugs.
person
Q&A
11:50AM
Audience
Audience is able to call in to the radio show, (515) 602-9728, to ask Dr. Shallis questions about what was discussed during our interview today.

Speakers & Moderators

The panelist Kerith Amen
Kerith Amen
New Orleans, Louisiana

Kerith joined HealthTree Foundation as a Community Co-Director for AML in 2022. She is a mother to a spirited eight-year-old daughter, Adair, and their beloved rescue, Violet. She lost her best friend and husband, Rob, to AML in March 2018. Kerith wishes she had a resource such as HealthTree for AML during Rob’s illness. She is a strong supporter of HealthTree's mission. She hopes that by sharing her experience, she may help other patients and caregivers navigate an AML diagnosis.

Read Bio
The panelist Rory Shallis, MD
Rory Shallis, MD
New Haven, CT

Dr. Shallis is focused on the care and research of patients with myeloid malignancies, particularly acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). He currently participates as an investigator in several clinical trials aimed at improving the outcomes of patients with AML and MDS. He is an author on more than 75 peer-reviewed publications and book chapters, most of which he was first author on. His work has been published in many prestigious journals.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

(800) 930-5159

email

Support@healthtree.org

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Jazz Pharmaceuticals
AbbVie
Amgen
Genentech
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube

 

Terms of Use and Privacy Policy     Newsroom     About    Donations    Find an AML Specialist     Newsletter     Learn     Connect

 

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

https://www.guidestar.org/profile/45-5354811